Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses.
Bayarri-Olmos R, Sutta A, Rosbjerg A, Mortensen MM, Helgstrand C, Nielsen PF, Pérez-Alós L, González-García B, Johnsen LB, Matthiesen F, Egebjerg T, Hansen CB, Sette A, Grifoni A, Antunes RDS, Garred P. Bayarri-Olmos R, et al. Among authors: rosbjerg a. Front Immunol. 2024 Dec 10;15:1412873. doi: 10.3389/fimmu.2024.1412873. eCollection 2024. Front Immunol. 2024. PMID: 39720734 Free PMC article.
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
Hansen CB, Jarlhelt I, Pérez-Alós L, Hummelshøj Landsy L, Loftager M, Rosbjerg A, Helgstrand C, Bjelke JR, Egebjerg T, Jardine JG, Sværke Jørgensen C, Iversen K, Bayarri-Olmos R, Garred P, Skjoedt MO. Hansen CB, et al. Among authors: rosbjerg a. J Immunol. 2021 Jan 1;206(1):109-117. doi: 10.4049/jimmunol.2000898. Epub 2020 Nov 18. J Immunol. 2021. PMID: 33208457
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
Bayarri-Olmos R, Idorn M, Rosbjerg A, Pérez-Alós L, Hansen CB, Johnsen LB, Helgstrand C, Zosel F, Bjelke JR, Öberg FK, Søgaard M, Paludan SR, Bak-Thomsen T, Jardine JG, Skjoedt MO, Garred P. Bayarri-Olmos R, et al. Among authors: rosbjerg a. J Immunol. 2021 Aug 1;207(3):878-887. doi: 10.4049/jimmunol.2100272. Epub 2021 Jul 23. J Immunol. 2021. PMID: 34301847
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
Jarlhelt I, Nielsen SK, Jahn CXH, Hansen CB, Pérez-Alós L, Rosbjerg A, Bayarri-Olmos R, Skjoedt MO, Garred P. Jarlhelt I, et al. Among authors: rosbjerg a. Front Immunol. 2021 Nov 2;12:767981. doi: 10.3389/fimmu.2021.767981. eCollection 2021. Front Immunol. 2021. PMID: 34804055 Free PMC article.
The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice.
Bayarri-Olmos R, Johnsen LB, Idorn M, Reinert LS, Rosbjerg A, Vang S, Hansen CB, Helgstrand C, Bjelke JR, Bak-Thomsen T, Paludan SR, Garred P, Skjoedt MO. Bayarri-Olmos R, et al. Among authors: rosbjerg a. Elife. 2021 Nov 25;10:e70002. doi: 10.7554/eLife.70002. Elife. 2021. PMID: 34821555 Free PMC article.
30 results